4.7 Article

Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene

Datong Zheng et al.

MOLECULAR CARCINOGENESIS (2017)

Article Physiology

KLF5 mediates vascular remodeling via HIF-1α in hypoxic pulmonary hypertension

Xiaochen Li et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)

Review Chemistry, Medicinal

Targeting Kruppel-Like Factor 5 (KLF5) for Cancer Therapy

Yu Gao et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)

Review Obstetrics & Gynecology

PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer

HaiXia Li et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)

Article Pharmacology & Pharmacy

Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype

B. Bhattacharya et al.

BRITISH JOURNAL OF PHARMACOLOGY (2014)

Review Cell Biology

Systems biology of cisplatin resistance: past, present and future

L. Galluzzi et al.

CELL DEATH & DISEASE (2014)

Article Multidisciplinary Sciences

Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway

Takehiro Yamamoto et al.

NATURE COMMUNICATIONS (2014)

Review Oncology

Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway

Howard A. Burris

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)

Article Biophysics

Cancer cell bioenergetics and pH regulation influence breast cancer cell resistance to paclitaxel and doxorubicin

Diana Tavares-Valente et al.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2013)

Article Biochemistry & Molecular Biology

Kruppel-like Factor 5 Transcription Factor Promotes Microsomal Prostaglandin E2 Synthase 1 Gene Transcription in Breast Cancer

Houjun Xia et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Review Pharmacology & Pharmacy

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

Gregg L. Semenza

TRENDS IN PHARMACOLOGICAL SCIENCES (2012)

Article Cell Biology

Novel insights into the molecular origins and treatment of lung cancer

James D. Webb et al.

CELL CYCLE (2010)

Review Oncology

Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients

Sandra E. Ghayad et al.

RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2010)

Review Biochemistry & Molecular Biology

Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases

Jin-Tang Dong et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2009)

Review Oncology

Multidrug Resistance Through the Spectacle of P-Glycoprotein

Katalin Goda et al.

CURRENT CANCER DRUG TARGETS (2009)

Article Oncology

Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression

Jean-Philippe Cosse et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade

A Street et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Review Biochemistry & Molecular Biology

Kruppel-like factors: Three fingers in many pies

JJ Bieker

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)